期刊文献+

比较钆塞酸二钠和钆喷酸葡胺增强MRI检查对乙肝肝硬化背景肝癌的诊断价值 被引量:9

Comparison of the Diagnostic Value with Gd-EOB-DTPA and Gd-DTPA for Hepatocellular Carcinomas( HCC) in Hepatitis B Induced Cirrhosis
原文传递
导出
摘要 目的探讨钆塞酸二钠(Gd-EOB-DTPA)MR扫描对乙肝肝硬化背景肝癌的诊断价值。方法 32例乙肝肝硬化患者共34个肝癌病灶,均行两种MR成像[模式1:T2WI、DWI、T1WI同反相位、Gd-DTPA动态增强(平扫、动脉期、门静脉期及延迟期);模式2:T2WI、DWI、T1WI同反相位、Gd-EOB-DTPA动态增强(平扫、动脉期、门静脉期、延迟期及肝胆期)]。由2名阅片者采用双盲法分析图像,记录病灶的信号特点、强化方式及阅片者的信心评分。比较两种成像模式下阅片者诊断肝癌信心评分、一致性、ROC曲线下的面积、敏感性及阳性预测值。结果 (1)模式2下两位阅片者诊断肝癌的信心评分均提高,差异有统计学意义(P<0.05);且2名阅片者在模式2下诊断肝癌的一致性均增加。(2)2名阅片者在模式2下诊断肝癌的ROC曲线下面积均较模式1增加,差异有统计学意义(P<0.05)。(3)2名阅片者在模式2下诊断肝癌的敏感性较模式1均提高,差异有统计学意义(P<0.05),阳性预测值差异均无统计学意义(P>0.05)。结论 Gd-EOB-DTPA MR扫描有助于提高阅片者对乙肝肝硬化背景肝癌的诊断信心从而提高诊断能力。 Objective To explore the diagnostic value of Gd-EOB-DTPA MRI for hepatocellular carcinomas( HCC) in hepatitis B induced cirrhosis. Methods A total of 32 cirrhotic patients with 34 HCC lesions,all underwent two imaging sets of MRI,the first imaging set: T2 WI,DWI,T1 WI in-phase and opposed-phase and enhanced imaging( native phase,arterial phase,portal-venous phase and late-phase); the second imaging set: T2 WI,DWI,T1 WI in-phase and opposedphase and enhanced imaging( native phase,arterial phase,portal-venous phase,late-phase and hepatobiliary phase). Two separate blind image analyses of the two imaging sets were performed. The signal characteristic of all lesions,the enhancement styles,and the confidence scores were recorded. The confidence scores of the two imaging sets,consistency,area under the receiver operating characteristic( ROC) curve,sensitivity and positive predictive values( PPV) were compared.Results( 1) The confidence scores of the observers for the second imaging set were higher than those of the first one by both observers and the differences were statistically significant( P 〈 0. 05). The consistency of the observers also increased.( 2) The area under the ROC curve improved by both observers for the second imaging set,and significant differences were detected( P 〈 0. 05).( 3) There was a significant increase of the diagnostic sensitivity of the two observers for the second imaging set( P 〈 0. 05). No significant differences were detected for the PPV by both observers( P 〉 0. 05).Conclusion Gd-EOB-DTPA MRI may improve the diagnostic efficacy of HCC in hepatitis B induced cirrhotic liver by increasing observer’s confidence.
出处 《临床放射学杂志》 CSCD 北大核心 2015年第9期1500-1504,共5页 Journal of Clinical Radiology
基金 南通市科技局社会发展项目(编号:S2013141) 南通市卫生局青年基金课题项目(编号:WQ2014039)
关键词 肝疾病 肝肿瘤 磁共振成像 GD-DTPA GD-EOB-DTPA Liver diseases Liver neoplasms Magnetic resonance imaging Gd-DTPA Gd-EOB-DTPA
  • 相关文献

参考文献11

  • 1丁伟伟,郭玉林,牛建栋,黄婷婷,蔡磊,陈勇,闫少宁,侯登华,朱凯.MR和CT动态增强扫描对肝硬化背景下小肝癌的比较研究[J].临床放射学杂志,2011,30(7):984-987. 被引量:21
  • 2Martino MD, Marin D, Guerrisi A, et al. Intraindividual Comparison of Gadoxetate Disodium-enhanced MR Imaging and 64-Section Multidetector CT in the Detection of Hepatocellular Carcinoma in Patients with Cirrhosis[J] . Radiology ,2010 ,256 :806-815.
  • 3Kanata N , Yoshikawa T, Ohno Y , et al. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT[J]. Magnetic Resonance Imaging,2013, 31 :17-220.
  • 4Inoue T,Kudo M,Komuta M,et al. Assessment of Gd-EOB-DTPAenhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT[J] . Journal of Gastroenterology , 2012,47:1036-1047.
  • 5严福华,周康荣,沈继章,曾蒙苏,杨军,吴东,龚静山,施卫斌.MR和CT动态扫描对小肝癌强化特征的比较研究[J].中华肿瘤杂志,2001,23(5):413-416. 被引量:82
  • 6程伟中,曾蒙苏.新型多功能磁共振对比剂Gd-EOB-DTPA在肝胆系统病变中的应用[J].临床放射学杂志,2005,24(12):1107-1110. 被引量:15
  • 7Carlos RC, Kim HM, Hussain HK, et al. Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis[J]. AJR, 2003 , 180 : 893 -900 .
  • 8Cruite I, Schro eder M, Merkle EM, et al. Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver] 1]. AJR ,2010,195 :2941.
  • 9Golfieri R, Renzulli M, Lucidi V, et al. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small ( <2 em) HCC in cirrhosis[J]. Eur Radiol ,2011 ,21 : 1233-1242.
  • 10Motosugi U, Ichikawa T, Sou H, et al. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging[J]. Radiology, 2010 ,256: 151-158.

二级参考文献33

  • 1张杰,卜庆丰.螺旋CT三期增强扫描诊断原发性小肝细胞癌的价值[J].中国医学影像学杂志,2006,14(4):307-309. 被引量:11
  • 2黄伟鹏,陈洁容,许建生,葛纪林,陈丽君.小肝癌的螺旋CT不典型表现并与病理对照[J].实用放射学杂志,2006,22(9):1087-1090. 被引量:26
  • 3Tsim NC, Frampton AE, Habib NA, et al. Surgical treatment for liver cancer. World J Gastroenterol,2010,16:927.
  • 4Oi H, Murakami T, Kim T, et al. Dynamic MR imaging and earlyphase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. A JR, 1996,166:369.
  • 5Lim KO, Stark DD, Leese PT,et al. Hepatobiliary MRI: first human experience with MnDPDP. Radiology, 1991, 178:79.
  • 6Witzleben CL, Pitlick P, Bergmeyer J,et al. Acute manganese overload: a new experiental model of intrahepatic cholestasis. Am J Pathol, 1968, 55:409.
  • 7Hamm B, Kirchin M, Pirovano G,et al. Clinical utility and safety of multihance in MRI of liver cancer: results of multicenter studies in europe and the USA. J Comput Assist Tomogr, 1999, 53.
  • 8Schuhmann-Giampieri G, Schmitt-Willich H, Press WR,et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology, 1992, 183:56.
  • 9Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H,et al. A new lipophilic gadoliniumchelate as a tissue-specific contrast medium for MR imaging. Magn Reson Med, 1991, 22:233.
  • 10Hamm B, Staks T, Muhler A,et al. Phase Ⅰ chinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging. Radiology, 1995, 195:785.

共引文献109

同被引文献54

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部